Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Thirumaran, K. Lilley, D. Saralaya, B. Jacob (Bradford, United Kingdom). Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging. Eur Respir J 2008; 32: Suppl. 52, 2615

Member's Comments

No comment yet.

Related content which might interest you: Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007 Computed tomography in staging for lung cancer Source: Eur Respir J 2002; 19: 40S-48S Year: 2002 The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245 Year: 2004 Diagnostic imaging of lung cancer Source: Eur Respir J 2002; 19: 722-742 Year: 2002 Diagnostic imaging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=120 Year: 2001 The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008 Radiologic and clinical outcomes of small pulmonary nodules detected on low-dose computed tomography Source: Annual Congress 2005 - Screening and imaging of lung cancer Year: 2005 Radiology of lung cancer Source: Eur Respir Mon; 2009: 44: 106–135 Year: 2009 Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 The use of SPECT in preoperative assessment of patients with lung cancer Source: Eur Respir J 2004; 24: 258-262 Year: 2004 Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion. Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases Source: Eur Respir J 2015; 46: 1196-1199 Year: 2015 Assessing nodules detected in lung cancer screening: the value of positron emission tomography Source: Eur Respir J 2015; 45: 314-316 Year: 2015 Imaging in lung cancer: positron emission tomography scan Source: Eur Respir J 2002; 19: 49S-60S Year: 2002 The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009 Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions Source: Eur Respir J 2007; 29: 1187-1192 Year: 2007